About Timber Pharmaceuticals
Meet the Team
Timber is committed to developing treatments for unmet needs in medical dermatology. To deliver on our promise to you, our team is made of world class advisors and a strong leadership team with a proven track record of success.
Michael Derby, MS, MBA
Michael is a successful biopharmaceutical entrepreneur, operating executive and investor. He has founded or co-founded multiple biopharmaceutical companies and has a passion for developing and commercializing innovative products that can make a major impact on the lives of patients globally.
John Koconis, MBA
CHIEF EXECUTIVE OFFICER
John has had a highly accomplished career as both a strategic and operational leader in the pharmaceutical sector with over 25 years of experience leading successful teams in global markets and launching multiple market-leading products. John brings a unique perspective through his experience in broad, specialty and rare/orphan dermatology development and commercialization.
CHIEF OPERATING OFFICER
Zach is a biopharmaceutical inventor, entrepreneur and executive. He is a Co-Founder of Timber and has served as the Company’s President since its inception. Zach is also a Partner at TardiMed Sciences, a life sciences company creation firm. At TardiMed, Zach has helped to form several life sciences companies that span multiple therapeutic areas and stages of development.
CHIEF FINANCIAL OFFICER
Joe is the Chief Financial Officer of Timber Pharmaceuticals as well as a Partner at TardiMed Sciences. Prior to joining TardiMed, he was a founding member and Managing Director of Oncology Partners, a boutique financial advisory firm serving development stage biotechnology companies and investors. Prior to founding Oncology Partners, Joe was a Managing Partner of Foundation Ventures, an investment banking firm servicing early stage life sciences companies.
Amir Tavakkol, PhD
CHIEF SCIENTIFIC OFFICER
Amir is a seasoned senior executive with over 25 years of drug development and medical affairs experience in large pharma/biotech, consumer healthcare and academia. He has led drug development as well as clinical development teams in dermatology and infectious diseases resulting in successful regulatory filings and product launches, patents/trademarks, and has authored ~60 high impact publications in leading medical and scientific journals.